Gide, counsel to Sofinnova Partners, Bpifrance and Novo Seeds on their investment in Lysogène

Gide has advised Sofinnova Partners, Bpifrance (via Innobio) and Novo Seeds on their 16.5-million-euro investment in the share capital of Lysogène, a pioneering biotechnology company in the field of gene therapy, focusing particularly on severe genetic pathologies affecting the central nervous system in children.

Legal counsel to Sofinnova Partners, Bpifrance and Novo Seeds:
Gide, Karen Noël (partner) and Margarita Lukashova.